The CDK7 inhibitor (CDK7i) LDC4297 caused similar, but weaker effects, and had higher half‐inhibitory concentrations (IC50) in different AML cell lines and primary AML cells (Appendix Fig S5D). The gene discussed is CDK7; the disease is acute myeloid leukemia.